Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Wells Antonia	2. Issuer Name and Ticker or Trading Symbol MERGE HEALTHCARE INC [ MRGE ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) President, International & R&D
(Last) (First) (Middle) 6303 AIRPORT ROAD,, SUITE 500	3. Date of Earliest Transaction (MM/DD/YYYY) 5/12/2014
(Street) MISSISSAUGA, A6 L4V 1R8 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	5/12/2014		M		50000	A	$0.68	61347	D
Common Stock	5/12/2014		S		1500	D	$2.12	59847	D
Common Stock	5/12/2014		S		100	D	$2.125	59747	D
Common Stock	5/12/2014		S		300	D	$2.1288	59447	D
Common Stock	5/12/2014		S		100	D	$2.129	59347	D
Common Stock	5/12/2014		S		9803	D	$2.13	49544	D
Common Stock	5/12/2014		S		100	D	$2.1318	49444	D
Common Stock	5/12/2014		S		200	D	$2.1345	49244	D
Common Stock	5/12/2014		S		100	D	$2.1394	49144	D
Common Stock	5/12/2014		S		5885	D	$2.14	43259	D
Common Stock	5/12/2014		S		200	D	$2.1451	43059	D
Common Stock	5/12/2014		S		100	D	$2.146	42959	D
Common Stock	5/12/2014		S		6590	D	$2.15	36369	D
Common Stock	5/12/2014		S		100	D	$2.1516	36269	D
Common Stock	5/12/2014		S		100	D	$2.1528	36169	D
Common Stock	5/12/2014		S		200	D	$2.1528	35969	D
Common Stock	5/12/2014		S		100	D	$2.1541	35869	D
Common Stock	5/12/2014		S		200	D	$2.1545	35669	D
Common Stock	5/12/2014		S		100	D	$2.1599	35569	D
Common Stock	5/12/2014		S		4299	D	$2.16	31270	D
Common Stock	5/12/2014		S		100	D	$2.1636	31170	D
Common Stock	5/12/2014		S		100	D	$2.164	31070	D
Common Stock	5/12/2014		S		100	D	$2.1649	30970	D
Common Stock	5/12/2014		S		100	D	$2.165	30870	D
Common Stock	5/12/2014		S		100	D	$2.1658	30770	D
Common Stock	5/12/2014		S		2800	D	$2.17	27970	D
Common Stock	5/12/2014		S		100	D	$2.1742	27870	D
Common Stock	5/12/2014		S		400	D	$2.1744	27470	D
Common Stock	5/12/2014		S		200	D	$2.1772	27270	D
Common Stock	5/12/2014		S		3800	D	$2.18	23470	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:
Performing option exercises prior to June 3, 2014 expiration. (Section 16 filing 1 of 2 for option exercises performed on each of 5/12/14 and 5/13/14.)

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Wells Antonia 6303 AIRPORT ROAD, SUITE 500 MISSISSAUGA, A6 L4V 1R8			President, International & R&D

Signatures
/s/ Julie Ann B. Schumitsch, by Power of Attorney for Antonia A. Wells		5/14/2014
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.